Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GAIC (Genetics and Insurance Committee) appointee looks to raise profile:

This article was originally published in Clinica

Executive Summary

The UK Department of Health has appointed Professor David Johns as new chair to the Genetics and Insurance Committee (GAIC). The appointment, billed by the government as a "first step in meeting our commitment to review and expand the membership of GAIC", is for a three-year period from December 1. Professor Johns is an engineering consultant, former vice-chancellor of Bradford University and was, until recently, chairman of the Prescription Pricing Authority. The GAIC was set up in April 1999 to develop criteria for evaluation of the scientific, medical and actuarial evidence available to support the use of genetic tests in insurance risk assessment and to evaluate specific tests against these criteria.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts